Aurobindo In Trouble Again With FDA, Gets Form 483 With 11 Observations

12 Apr 2019

• By Penelope MacRae

The US Food and Drug Administration has flagged more problems at Aurobindo, issuing another Form 483 to the company over one of its plants in southern India. This one, containing 11 observations, sharply faults quality controls.

Factory — Aurobindo’s Bachupally Plant Was Inspected In February • Source: Shutterstock

Aurobindo In Trouble Again With FDA, Gets Form 483 With 11 Observations

More from Manufacturing

More from Business